1. Home
  2. CMCO vs OCGN Comparison

CMCO vs OCGN Comparison

Compare CMCO & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

HOLD

Current Price

$17.84

Market Cap

555.6M

Sector

Industrials

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.44

Market Cap

474.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCO
OCGN
Founded
1875
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.6M
474.8M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
CMCO
OCGN
Price
$17.84
$1.44
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$21.00
$9.75
AVG Volume (30 Days)
718.9K
4.2M
Earning Date
05-27-2026
05-05-2026
Dividend Yield
1.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$936,240,000.00
N/A
Revenue This Year
$19.73
N/A
Revenue Next Year
$82.91
$1,718.38
P/E Ratio
N/A
N/A
Revenue Growth
3.27
N/A
52 Week Low
$11.99
$0.99
52 Week High
$24.40
$2.73

Technical Indicators

Market Signals
Indicator
CMCO
OCGN
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CMCO
OCGN

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a world-wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Its key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements. The company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: